Valuation: Bure Equity AB

Market Cap 23.38B 2.35B 2.07B 1.95B 1.78B 3.32B 226B 3.35B 9.06B 115B 8.82B 8.63B 374B P/E 2024
4.94x
P/E 2025 -3.91x
Enterprise Value 23.04B 2.32B 2.04B 1.92B 1.75B 3.28B 222B 3.3B 8.93B 113B 8.69B 8.51B 368B EV / Sales 2024
4.74x
EV / Sales 2025 -3.91x
Free-Float
70.33%
Yield 2024
0.72%
Yield 2025 1.11%
1 day+2.87%
1 week+4.75%
Current month+2.22%
1 month+2.09%
3 months+25.21%
6 months+48.16%
Current year+30.39%
1 week 312.8
Extreme 312.8
325
1 month 294.8
Extreme 294.8
330.6
Current year 190.2
Extreme 190.2
330.6
1 year 190.2
Extreme 190.2
330.6
3 years 190.2
Extreme 190.2
421.2
5 years 171.3
Extreme 171.3
474.6
10 years 86.8
Extreme 86.8
489.2
Manager TitleAgeSince
Chief Executive Officer 55 22/04/2013
Director of Finance/CFO 58 01/10/2013
Chief Investment Officer 46 01/01/2019
Director TitleAgeSince
Director/Board Member 56 30/04/2010
Chairman 62 22/04/2013
Director/Board Member 60 04/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
21/8/26 Buy

Director

1,100 0.0015%
1/6/26 Buy

Chief Financial Officer

1,069 0.0014%
26/5/26 Buy 67,000 0.0904%
Change 5-day change 1-year change 3-year change Capi.($)
+2.78%+4.75%+18.22%+51.51% 2.35B
+1.02%+1.25%+43.01%+92.05% 125B
+1.25%+1.76%+49.92%+88.08% 23.42B
+1.09%+1.34%+23.99%+47.26% 16.9B
-2.56%-0.63%+8.09%+118.82% 14.76B
+1.32%+2.06%+23.96%+29.18% 14.63B
+0.53%+1.50%-5.81%+8.54% 13.37B
-0.18%-3.45%-15.56%+49.56% 12.65B
+0.08%-0.15%+71.88%+82.94% 12.91B
-3.85%+3.08%+17.65%+35.36% 12.86B
Average +0.16%+0.75%+23.53%+60.33% 24.89B
Weighted average by Cap. +0.49%+0.39%+33.53%+76.09%

Financials

2024 2025
Net sales 5.81B 584M 513M 484M 442M 826M 56.02B 832M 2.25B 28.51B 2.19B 2.14B 92.78B -4.6B -462M -407M -383M -350M -654M -44.39B -659M -1.78B -22.59B -1.74B -1.7B -73.51B
Net income 5.74B 577M 508M 478M 437M 816M 55.39B 823M 2.23B 28.19B 2.17B 2.12B 91.74B -4.68B -470M -414M -390M -356M -665M -45.13B -670M -1.81B -22.97B -1.77B -1.73B -74.74B
Net Debt -779M -78.29M -68.86M -64.92M -59.23M -111M -7.52B -112M -302M -3.82B -294M -288M -12.45B -339M -34.07M -29.97M -28.25M -25.77M -48.2M -3.27B -48.58M -131M -1.66B -128M -125M -5.42B
Logo Bure Equity AB
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Employees
12
Date Price Change Volume
25/09/26 SEK 322.00 +2.81% 44,138
24/09/26 SEK 313.20 -2.00% 71,532
23/09/26 SEK 319.60 +1.01% 78,918
22/09/26 SEK 316.40 -0.50% 68,169
21/09/26 SEK 318.00 +3.52% 84,545
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. BURE Stock